Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: S&P Capital IQ Quantitative Report
$115.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cross Country Healthcare Inc Issues Q2 2013 Guidance Below Analysts' Estimates


Tuesday, 7 May 2013 05:00pm EDT 

Cross Country Healthcare Inc announced that for the second quarter of 2013, it expects revenue to be in the $110.0 million to $112.0 million range and loss per diluted share from continuing operations to be in the range of $0.01 to $0.03. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $113 million and EPS of $0.01 for the second quarter of 2013. 

Company Quote

8.64
0.23 +2.73%
4:00pm EDT